20th July 2015
20 JULY 2015 OPENING OF US MARKET FOR IOLCP
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has received from US Food and Drug Administration (USFDA) Establishment Inspection Report dated 25 June 2015 after successful inspection of the Ibuprofen manufacturing facilities of Company situated at Barnala, Punjab. This will facilitate the company to expand its market to US.
A copy of the press release is attached herewith for your information